Delayed release softgel capsules in higher pH environment
Disclosed in certain embodiments is a delayed release softgel capsules comprise a fill material that is encapsulated in a pH dependent shell composition, the pH dependent shell composition including pectin and gellan gum. Also disclosed are methods of preparing any of the delayed release softgel capsules described herein and methods of use thereof.
1 . A delayed release softgel capsule comprising:
(a) a fill material; and
(b) a shell composition,
wherein the fill material comprises at least one active agent, and
wherein the shell composition comprises gelatin and a pH dependent polymer comprising pectin and gellan gum, wherein a ratio of the pectin to gellan gum is from about 10:1 to about 24:1, and about 0.01 wt % to about 2 wt % of dextrose, wherein the shell composition does not rupture at a pH of 4 at 15 minutes, 30 minutes, 45 minutes or 60 minutes when measured with a USP Apparatus II with paddles at 50 RPM, 900 ml 0.1N HCL acidic media adjusted to pH with phosphate buffer.
2 . The delayed release softgel capsule of claim 1 , wherein the shell composition does not rupture at a pH of 5 at 15 minutes, 30 minutes, 45 minutes or 60 minutes when measured with a USP Apparatus II with paddles at 50 RPM, 900 ml 0.1N HCL acidic media adjusted to pH with phosphate buffer.
3 . The delayed release softgel capsule of claim 1 , wherein the shell composition does not rupture at a pH of between 5 and 6 at 15 minutes, 30 minutes, 45 minutes or 60 minutes when measured with a USP Apparatus II with paddles at 50 RPM, 900 ml 0.1N HCL acidic media adjusted to pH with phosphate buffer.
4 . The delayed release softgel capsule of claim 1 , wherein the shell composition does not rupture at a pH of between 6 and 7 at 15 minutes, 30 minutes, 45 minutes, or 60 minutes, when measured with a USP Apparatus II with paddles at 50 RPM, 900 ml 0.1N HCL acidic media adjusted to pH with phosphate buffer.
5 . The delayed release softgel capsule of claim 1 , wherein the shell composition does not rupture at a pH of between 7 and 8 at 15 minutes, 30 minutes, 45 minutes, or 60 minutes when measured with a USP Apparatus II with paddles at 50 RPM, 900 ml 0.1N HCL acidic media adjusted to pH with phosphate buffer.
6 . The delayed release softgel capsule of claim 1 , wherein the shell composition does not rupture at a pH of between 8 and 8.4 at 15 minutes, 30 minutes, 45 minutes, or 60 minutes when measured with a USP Apparatus II with paddles at 50 RPM, 900 ml 0.1N HCL acidic media adjusted to pH with phosphate buffer.
7 . The delayed release softgel capsule of claim 1 , wherein the shell composition is derived from a wet mass comprising 0.1 to 5% gellan gum.
8 . The delayed release softgel capsule of claim 7 , wherein the wet mass further comprises from about 2% to about 10% pectin.
9 . The delayed release softgel capsule of claim 1 , wherein the shell composition comprises about 40 wt % to about 80 wt % of a gelatin, based on total weight of the dry shell composition.
10 . The delayed release softgel capsule of claim 1 , wherein the shell composition comprises about 0.1 wt % to about 10 wt % or about 0.4 wt % to about 5 wt % of gellan gum, based on total weight of the dry shell composition.
11 . The delayed release softgel capsule of claim 1 , wherein the shell composition comprises about 0.1 wt % to about 10 wt % or about 2 wt % to about 20 wt % of pectin, based on total weight of the dry shell composition.
12 . A process for preparing a delayed release softgel capsule according to claim 1 comprising the steps of:
preparing a fill material comprising an active agent; and
encapsulating the fill material with a shell composition, wherein the shell composition comprises gelatin and a pH dependent polymer comprising pectin and gellan gum, wherein the shell composition does not rupture at a pH of 4 at 15 minutes, 30 minutes, 45 minutes or 60 minutes when measured with a USP Apparatus II with paddles at 50 RPM, 900 ml 0.1N HCL acidic media adjusted to pH with phosphate buffer.
13 . A method of delivering an active agent to a target location within the gastrointestinal tract, the method comprising administering to a subject the delayed release softgel capsule according to claim 1 ,
wherein the shell composition of the delayed release softgel capsule dissolves/disintegrates in a pH of the target location in up to about 120 minutes, in up to about 90 minutes, in up to about 60 minutes, in up to about 30 minutes, or in up to about 15 minutes, and
wherein the shell composition of the delayed release softgel capsule does not dissolve/disintegrate or does not substantially dissolve/disintegrate in a pH that is lower than the pH of the target location in up to about 120 minutes, in up to about 90 minutes, in up to about 60 minutes, in up to about 30 minutes, or in up to about 15 minutes.